Literature DB >> 30989167

Ketone body can be a fuel substrate for failing heart.

Michinari Nakamura1, Junichi Sadoshima1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30989167      PMCID： PMC6704386          DOI： 10.1093/cvr/cvz104

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  15 in total

Review 1.  Mechanisms of physiological and pathological cardiac hypertrophy.

Authors:  Michinari Nakamura; Junichi Sadoshima
Journal:  Nat Rev Cardiol       Date:  2018-07       Impact factor: 32.419

Review 2.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

3.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

Review 4.  Myocardial fatty acid metabolism in health and disease.

Authors:  Gary D Lopaschuk; John R Ussher; Clifford D L Folmes; Jagdip S Jaswal; William C Stanley
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

Review 5.  Ketone bodies as signaling metabolites.

Authors:  John C Newman; Eric Verdin
Journal:  Trends Endocrinol Metab       Date:  2013-10-18       Impact factor: 12.015

6.  Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.

Authors:  Kenneth C Bedi; Nathaniel W Snyder; Jeffrey Brandimarto; Moez Aziz; Clementina Mesaros; Andrew J Worth; Linda L Wang; Ali Javaheri; Ian A Blair; Kenneth B Margulies; J Eduardo Rame
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

7.  The Failing Heart Relies on Ketone Bodies as a Fuel.

Authors:  Gregory Aubert; Ola J Martin; Julie L Horton; Ling Lai; Rick B Vega; Teresa C Leone; Timothy Koves; Stephen J Gardell; Marcus Krüger; Charles L Hoppel; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Daniel P Kelly
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

8.  The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.

Authors:  Yun-Hee Youm; Kim Y Nguyen; Ryan W Grant; Emily L Goldberg; Monica Bodogai; Dongin Kim; Dominic D'Agostino; Noah Planavsky; Christopher Lupfer; Thirumala D Kanneganti; Seokwon Kang; Tamas L Horvath; Tarek M Fahmy; Peter A Crawford; Arya Biragyn; Emad Alnemri; Vishwa Deep Dixit
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

9.  Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling.

Authors:  Rebecca C Schugar; Ashley R Moll; D André d'Avignon; Carla J Weinheimer; Attila Kovacs; Peter A Crawford
Journal:  Mol Metab       Date:  2014-08-13       Impact factor: 7.422

10.  Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.

Authors:  Masaru Obokata; Kazuaki Negishi; Hiroaki Sunaga; Hideki Ishida; Kyoko Ito; Tetsuya Ogawa; Tatsuya Iso; Yoshitaka Ando; Masahiko Kurabayashi
Journal:  J Am Heart Assoc       Date:  2017-10-03       Impact factor: 5.501
View more
  5 in total

1.  Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression.

Authors:  Jun-Yu Huo; Wan-Ying Jiang; Shi-Geng Zhang; Yi-Ting Lyu; Jie Geng; Meng Chen; Yuan-Yuan Chen; Zhi-Xin Jiang; Qi-Jun Shan
Journal:  Lab Invest       Date:  2021-11-13       Impact factor: 5.662

2.  Trimetazidine Ameliorates Myocardial Metabolic Remodeling in Isoproterenol-Induced Rats Through Regulating Ketone Body Metabolism via Activating AMPK and PPAR α.

Authors:  Huihui Li; Zhi Ma; Yajun Zhai; Chao Lv; Peng Yuan; Feng Zhu; Liping Wei; Qi Li; Xin Qi
Journal:  Front Pharmacol       Date:  2020-08-14       Impact factor: 5.810

3.  Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure.

Authors:  Michinari Nakamura; Natalija Odanovic; Yasuki Nakada; Satomi Dohi; Peiyong Zhai; Andreas Ivessa; Zhi Yang; Maha Abdellatif; Junichi Sadoshima
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 13.081

4.  β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes-Adding Fuel to the Fire?

Authors:  Xiurui Ma; Zhen Dong; Jingyi Liu; Leilei Ma; Xiaolei Sun; Rifeng Gao; Lihong Pan; Jinyan Zhang; Dilan A; Jian An; Kai Hu; Aijun Sun; Junbo Ge
Journal:  Cardiovasc Drugs Ther       Date:  2021-10-15       Impact factor: 3.947

5.  Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in elderly patients with comorbid coronary heart disease and diabetes mellitus.

Authors:  Hu Xu; Wen-Zhe Cao; Yong-Yi Bai; Rui-Hua Cao; Lei Tian; Feng Cao; Li Fan
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.327
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.